SCHEMBL6430701

SCHEMBL6430701

COc1cc2c(Nc3ccc(C)c(O)c3)ccnc2cc1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.58
KDR P35968 3/20 0.57
RET P07949 2/20 0.57
KIF5B P33176 2/20 0.57
GAK O14976 3/20 0.53
BMPR1B O00238 1/20 0.51
EPHB6 O15197 1/20 0.51
RIPK2 O43353 1/20 0.51
ABL1 P00519 1/20 0.51
LCK P06239 1/20 0.51
SRC P12931 1/20 0.51
EPHA1 P21709 1/20 0.51
EPHA8 P29322 1/20 0.51
ACVR1 Q04771 1/20 0.51
MAP2K5 Q13163 1/20 0.51
COQ8A Q8NI60 1/20 0.51
NLK Q9UBE8 1/20 0.51
PDGFRA P16234 1/20 0.49
CTSV O60911 2/20 0.48
CTSL P07711 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6434111 0.99 EGFR (0.57) EGFRKDRRETKIF5BGAK
SCHEMBL6434027 0.89 EGFR (0.72) EGFRKDRRETKIF5BGAK
Hydrochloric Acid SCHEMBL6433098 0.85 EGFR (0.54) EGFRKDRGAKBMPR1BEPHB6
SCHEMBL7864670 0.85 KDR (0.80) EGFRKDRRETKIF5BGAK
SCHEMBL6431478 0.85 FGFR1 (0.62) EGFRKDRRETKIF5BGAK
Hydrochloric Acid SCHEMBL6430782 0.84 FGFR1 (0.61) EGFRKDRRETKIF5BGAK
SCHEMBL1387146 0.82 EGFR (0.62) EGFRKDRGAKBMPR1BEPHB6
SCHEMBL6450143 0.82 CTSV (0.45) EGFRKDRRETKIF5BGAK
Hydrochloric Acid SCHEMBL8808103 0.81 EGFR (0.61) EGFRKDRGAKBMPR1BEPHB6
SCHEMBL2063817 0.80 EGFR (0.55) EGFRKDRRETGAKBMPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1252054-C Qinoline derivatives inhibiting effect of growth factors such as VEGF ZENECA LTD (GB) 2006-04-19 CN claimed
EP-0929526-B1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ASTRAZENECA AB (SE) 2005-07-27 EP claimed
US-6809097-B1 ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY ZENECA LIMITED (GB) 2004-10-26 US claimed
EP-0929526-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1999-07-21 EP claimed
WO-1998013350-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1998-04-02 WO claimed
CN-1252054-C Qinoline derivatives inhibiting effect of growth factors such as VEGF ZENECA LTD (GB) 2006-04-19 CN disclosed
EP-0929526-B1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ASTRAZENECA AB (SE) 2005-07-27 EP disclosed
US-6809097-B1 ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY ZENECA LIMITED (GB) 2004-10-26 US disclosed
EP-0929526-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1999-07-21 EP disclosed
WO-1998013350-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1998-04-02 WO disclosed